These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2142293)

  • 1. [The effect of ipratropium bromide on lung function in patients with cystic fibrosis].
    Wiebicke W; Poynter A; Montgomery M; Pagtakhan R
    Pneumologie; 1990 Feb; 44 Suppl 1():277-8. PubMed ID: 2142293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ
    Ann Allergy; 1988 Nov; 61(5):341-3. PubMed ID: 2973269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study.
    Friberg S; Graff-Lonnevig V
    Ann Allergy; 1989 Feb; 62(2):131-4. PubMed ID: 2521989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis.
    Sanchez I; De Koster J; Holbrow J; Chernick V
    Chest; 1993 Sep; 104(3):842-6. PubMed ID: 8365299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator response in adult patients with cystic fibrosis: effects on large and small airways.
    van Haren EH; Lammers JW; Festen J; van Herwaarden CL
    Eur Respir J; 1991 Mar; 4(3):301-7. PubMed ID: 1830849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
    Jorquera J; Díaz O; Lisboa C
    Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of montelukast on lung function and clinical symptoms in patients with cystic fibrosis].
    Stelmach I; Korzeniewska A; Smejda K; Jarosz I; Stelmach W
    Pneumonol Alergol Pol; 2004; 72(3-4):85-9. PubMed ID: 15757268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF.
    Weintraub SJ; Eschenbacher WL
    Chest; 1989 Apr; 95(4):861-4. PubMed ID: 2522385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis.
    Ziebach R; Pietsch-Breitfeld B; Bichler M; Busch A; Riethmüller J; Stern M
    Pediatr Pulmonol; 2001 Jun; 31(6):431-5. PubMed ID: 11389575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.
    Hartl D; Starosta V; Maier K; Beck-Speier I; Rebhan C; Becker BF; Latzin P; Fischer R; Ratjen F; Huber RM; Rietschel E; Krauss-Etschmann S; Griese M
    Free Radic Biol Med; 2005 Aug; 39(4):463-72. PubMed ID: 16043018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of DNase on exercise capacity in cystic fibrosis.
    Barker M; Franke E; Böhle M; Pfannenstiel C; Heimann G
    Pediatr Pulmonol; 2004 Jul; 38(1):70-4. PubMed ID: 15170876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in lung function measured by spirometry and the forced oscillation technique in cystic fibrosis patients undergoing treatment for respiratory tract exacerbation.
    Ren CL; Brucker JL; Rovitelli AK; Bordeaux KA
    Pediatr Pulmonol; 2006 Apr; 41(4):345-9. PubMed ID: 16496336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of ipratropium bromide inhalation in stable asthma.
    Ailani RK; Shah SP; Koyande D; Kudalkar SS; Kodge K; Deshmukh YA
    J Assoc Physicians India; 1995 Jan; 43(1):36, 41. PubMed ID: 9282638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dornase alpha and exhaled NO in cystic fibrosis.
    Grasemann H; Lax H; Treseler JW; Colin AA
    Pediatr Pulmonol; 2004 Nov; 38(5):379-85. PubMed ID: 15390350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the bronchodilator efficacy of nebulized pirenzepine and ipratropium bromide in patients with airway obstructive lung disease.
    Ceyhan B; Celikel T; Simsir S; Kandemir B
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):510-3. PubMed ID: 8262690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.
    Grasemann H; Kurtz F; Ratjen F
    Am J Respir Crit Care Med; 2006 Jul; 174(2):208-12. PubMed ID: 16627863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Function studies of an atropine derivative--ipratropium bromide in an aerosol device--in patients with chronic obstructive bronchopneumopathies].
    Mairesse M; Ledent C
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):196-9. PubMed ID: 162192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.